Knockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro

Molecular and Cellular Neuroscience

Volumn 47, Issue 2, 2011, Pages 93-99

  MacLaren, Erik J ^a   Charlesworth, Paul ^a   Coba, Marcelo P ^a   Grant, Seth G N ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Dctn5; Disc1; Dlg2; Multielectrode array; Neuronal culture; Tnik

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; MEMBRANE PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 93; PROTEIN TNIK; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; GENE CONTROL; GENE SILENCING; GENETIC CODE; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; IN VITRO STUDY; MENTAL DISEASE; MOUSE; NERVE CELL CULTURE; NERVE CELL NETWORK; NEUROPHYSIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE; SCHIZOPHRENIA;

ANIMALS; BIPOLAR DISORDER; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; GUANYLATE KINASE; HIPPOCAMPUS; HUMANS; MENTAL DISORDERS; MICE; NERVE NET; NERVE TISSUE PROTEINS; NEURONS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; SCHIZOPHRENIA; TUMOR SUPPRESSOR PROTEINS;

EID: 79955973557     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.12.014     Document Type: Article

References (33)

1. Adler C.M., DelBello M.P., Strakowski S.M. Brain network dysfunction in bipolar disorder. CNS Spectr. 2006, 11(4):312-320. quiz 323-4.
2. Arnold F.J., Hofmann F., Bengtson C.P., Wittmann M., Vanhoutte P., Bading H. Microelectrode array recordings of cultured hippocampal networks reveal a simple model for transcription and protein synthesis-dependent plasticity. J. Physiol. 2005, 564(Pt 1):3-19.
3. Blumberg H.P., Kaufman J., Martin A., Charney D.S., Krystal J.H., Peterson B.S. Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder. Ann. N. Y. Acad. Sci. 2004, 1021:376-383.
4. Brewer G.J., Boehler M.D., Pearson R.A., DeMaris A.A., Ide A.N., Wheeler B.C. Neuron network activity scales exponentially with synapse density. J. Neural Eng. 2009, 6(1):014001.
5. Burton P.R., et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.
6. Carlisle H.J., Fink A.E., Grant S.G., O'Dell T.J. Opposing effects of PSD-93 and PSD-95 on long-term potentiation and spike timing-dependent plasticity. J. Physiol. 2008, 586(Pt 24):5885-5900.
7. Chiappalone M., Bove M., Vato A., Tedesco M., Martinoia S. Dissociated cortical networks show spontaneously correlated activity patterns during in vitro development. Brain Res. 2006, 1093(1):41-53.
8. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 2005, 42(3):193-204.
9. DeGiorgis J.A., Galbraith J.A., Dosemeci A., Chen X., Reese T.S. Distribution of the scaffolding proteins PSD-95, PSD-93, and SAP97 in isolated PSDs. Brain Cell Biol. 2006, 35(4-6):239-250.
10. Ford J.M., Krystal J.H., Mathalon D.H. Neural synchrony in schizophrenia: from networks to new treatments. Schizophr. Bull. 2007, 33(4):848-852.
11. Gramowski A., Jugelt K., Weiss D.G., Gross G.W. Substance identification by quantitative characterization of oscillatory activity in murine spinal cord networks on microelectrode arrays. Eur. J. Neurosci. 2004, 19(10):2815-2825.
12. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 2007, 78:69-108.
13. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., Roberts R.C. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol. 2006, 497(3):436-450.
14. Komiyama N.H., Watabe A.M., Carlisle H.J., Porter K., Charlesworth P., Monti J., Strathdee D.J., O'Carroll C.M., Martin S.J., Morris R.G., O'Dell T.J., Grant S.G. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci. 2002, 22(22):9721-9732.
15. Krieckhaus E.E., Donahoe J.W., Morgan M.A. Paranoid schizophrenia may be caused by dopamine hyperactivity of CA1 hippocampus. Biol. Psychiatry 1992, 31(6):560-570.
16. Kristiansen L.V., Beneyto M., Haroutunian V., Meador-Woodruff J.H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 2006, 11(8):737-747. 705.
17. Kwinter D.M., Lo K., Mafi P., Silverman M.A. Dynactin regulates bidirectional transport of dense-core vesicles in the axon and dendrites of cultured hippocampal neurons. Neuroscience 2009, 162(4):1001-1010.
18. Laird F.M., Farah M.H., Ackerley S., Hoke A., Maragakis N., Rothstein J.D., Griffin J., Price D.L., Martin L.J., Wong P.C. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J. Neurosci. 2008, 28(9):1997-2005.
19. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 2002, 25:409-432.
20. Lodge D.J., Grace A.A. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J. Neurosci. 2007, 27(42):11424-11430.
21. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9(9):1415-1423.
22. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310(5751):1187-1191.
23. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98(4):427-436.
24. Munch C., Rosenbohm A., Sperfeld A.D., Uttner I., Reske S., Krause B.J., Sedlmeier R., Meyer T., Hanemann C.O., Stumm G., Ludolph A.C. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 2005, 58(5):777-780.
25. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
26. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464(7289):763-767.
27. Stone J.L., et al. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(7210):237-241.
28. Uhlhaas P.J., Singer W. What do disturbances in neural synchrony tell us about autism?. Biol. Psychiatry 2007, 62(3):190-191.
29. Valor L.M., Charlesworth P., Humphreys L., Anderson C.N., Grant S.G. Network activity-independent coordinated gene expression program for synapse assembly. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(11):4658-4663.
30. Wagenaar D.A., Pine J., Potter S.M. An extremely rich repertoire of bursting patterns during the development of cortical cultures. BMC Neurosci. 2006, 7:11.
31. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543.
32. Wang Q., Charych E.I., Pulito V.L., Lee J.B., Graziane N.M., Crozier R.A., Revilla-Sanchez R., Kelly M.P., Dunlop A.J., Murdoch H., Taylor N., Xie Y., Pausch M., Hayashi-Takagi A., Ishizuka K., Seshadri S., Bates B., Kariya K., Sawa A., Weinberg R.J., Moss S.J., Houslay M.D., Yan Z., Brandon N.J. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol. Psychiatry 2010, September 14 epub online.
33. Wong R.O., Meister M., Shatz C.J. Transient period of correlated bursting activity during development of the mammalian retina. Neuron 1993, 11(5):923-938.